Skip to main content
. Author manuscript; available in PMC: 2019 Dec 17.
Published in final edited form as: Am J Intellect Dev Disabil. 2014 Jan;119(1):1–16. doi: 10.1352/1944-7558-119.1.1

Table 1.

Comparison of the PARS-R to Other Measures Previously Used in FXS

Scale Format & length Study Normative samples Reliability & validity Strengths Weaknesses

Pediatric Anxiety Rating Scale/ Pediatric Anxiety Rating Scale-Revised Parent/Child Clinician-rated interview(30–45 min.) Riddle et al.,2002 128 children, ages 2002 6–17 years(DSM-IV diagnosis of SoP, SAD, or GAD) ICC = .97;α= .64; ICC = .55; r = .61 (CGI-S) Used with pediatric populations and with developmental disabilities; clinically-sensitive, wide-range of anxiety symptom coverage, continuous distribution of scores; originally intended to be an outcome measure; sensitive to psychopharmacological treatment of anxiety Not originally intended for populations with developmental disabilities; does not render sub-categorization of anxiety
Storch et al.,2012 72 children, ages 7–17 years(diagnosis of autism, Asperger’s syndrome, or PDD-NOS & GAD,SAD, SA, or OCD) ICC = .86; α= .59; ICC = .83
Anxiety, Depression, and Mood Scale Caregiver-rated questionnaire (15 min.) Esbensen et al.,2003 265 subjects, ages 10–79 years of age (diagnosisof MR) ICC = .75–.83; α= .48 (Full scale); α= .37–.62(subscales);ICC = .81 (Full scale); ICC 5.72–.83 (subscales) Established data in FXS; validated against DSM-IV; normed and developed forintellectual disability Does not have anestablished track record, limited anxiety symptom coverage, not intended as outcome measure
Anxiety Disorders Interview Schedule-IV Parent/Child Clinician-rated interview (1 hr.) Silverman, Saavedra,& Pina,2001 62 children, ages 7–16 years and their parents (exclusion criteria:developmental delays and severe psychopathology) ICC =.78–.96 (Symptom scales); κ = .80 to .92(Combined diagnoses of these disorders); κ = .63–.80 (child-only interview); κ = .65–.88(parent-only interview); r = .94(parent); r = .92(child) Used with pediatric populations and with developmental disabilities; used in assessment of DSM-IV anxiety disorders Assesses anxiety over the past year and therefore not an effective outcome measure; not a continuous measure of severity
Aberrant Behavior Checklist-Community Edition Caregiver-rated questionnaire (15 min.) Aman et al.,1995 927 institutionalized, profoundly developmentally delayed adolescents and adults ICC −.86–.94; α = .96–.99 Used with pediatric populations and with developmental disabilities; used in many FXS clinical trials; offers ratings of behaviors that may be present when anxious(e.g., inappropriate speech); sensitive to treatment effects Does not have anxiety subscales; many symptoms not relevant for higher functioning patients without ID
Child Behavior Checklist Caregiver-rated questionnaire (20 min.) Achenbach,1991 2,368 nationally-representative children, ages 4–18 years without disabilities ICC = .92–.96; α = .83–.92 Used with pediatric populations; provides broad-band internalizing and externalizing scores and narrow-band scaled scores Not generally used as outcome measure; many itemsinappropriate for developmental/ intellectual disability; not specifically normed in ID
Clinical Global Impression-Severity Scale Clinical impression (10 min.) Forkman et al.,2011 31 inpatient adults with major depressive disorder ICC = .22–.24 Used with pediatric populations and developmental disabilities; used in controlled treatment studies No specific interviewer guide available so response format can be ambiguous
Multidimensional Anxiety Questionnaire Self-report questionnaire (10 min.) Reynolds,1999 More than 1,800college students,600 community adults, 407 psychiatric outpatients diagnosed with anxiety-related or other disorders α = .96 (Total scale); α = .88 to .91(subscales); α = .95(Total scale); α =.90–.93 (subscales) Used with women with pre-mutation FXS; provides global assessment of DSM-IV anxiety symptoms in four domains; provides a cutoff score for clinically relevant anxiety; easy to administer/score screener; clinically valid Not used with pediatric populations; self-report may not be possible for some individuals with developmental disabilities; onlynormed for 18 and older